Azorin,
Jean-Michel, et al. A Double-Blind Comparative Study of Clozapine and
Risperidone in the Management of Sever Chronic Schizophrenia. American
Journal of Psychiatry 158 (2001): 1305-1313.
Carpenter,
William, et al. A Comparative Trial of Pharmacologic Strategies in
Schizophrenia American Journal of Psychiatry 144 (1987): 1466-1470.
Conley,
Robert and Mahmoud, Ramy. A Randomized Double-Blind study of Risperidone and
Olanzapine in the Treatment of Shizophrenia or Schizoaffective Disorder
American Journal of Psychiatry 158 (2001): 765-774.
Cooper,
SJ, et al. Zotepine in the Prevention of Recurrence: A Randomised,
Double-Blind, Placebo-Controlled Study for Chronic Schizophrenia Psychopharmacology
150 (2000) 237-243.
Kane,
Jonathon and De Scipio, William. Acupuncture Treatment of Schizophrenia:
Report on Three Cases American Journal of Psychiatry 136 (1979):
297-302.
Kane,
J, et al. Clozaril Collaborative Group: Clozapine for Treatment-Resistant
Schizophrenia: A double-blind Comparison with Chlorpromazine Archives of
General Psychiatry 45 (1988): 789-796.
May,
Philip, Tuma, Hussain, and Dixon, Wilfrid. For Better or For Worse? The
Journal of Nervous and Mental Disease 165 (1977): 231-239.
Schreiber, Stephen et al. Dialysis for Schizophrenia: An Uncontrolled Study of 11 Patients. American Journal of Psychiatry 138 (1981): 662-665.
Srmaek,
John, et al. A Carbamazepine Trial in Chronic, Treatment-Refractory
Schizophrenia American Journal of Psychiatry 145 (1988): 145-146.
Wagemaker,
H Jr, and Cade R. The use of
Hemodialysis in Chronic Schizophrenia American Journal of Psychiatry
134 (1977): 684-685
Young,
Carl, et al. The Expanding Indications for Clozapine Experimental and
Clinical Psychopharmacology 5.3 (1997): 216-234.
Bruno,
F. Buspirone in the Treatment of Alcoholic Patients. Psychopathology
Suppl. 1 (1989): 46-59.
Davidson
D et al The Effects of Naltrexone on Alcohol Self-Administration in Heavy
Drinkers. Alcohol: Clinical
and Experimental Research 23(1999): 195-203.
Dorus,
1989, et al. Lithium Treatment of Depressed and Nondepressed Alcoholics JAMA
262 (1989): 1646-1652.
Doty
P, Zacny J, and deWit H. The Effects of Ondansetron Pretreatment on Acute
Responses to Ethanol in Social Drinkers. Behavioral Pharmacology 5(1994):
461-469.
Fawcett, Jan et al. Pharmacological Treatments for Alcoholism: Revisiting LIthium and Considering Buspirone Alcoholism: Clinicla and Experimental Research 24 (2000): 666-673
Humphreys, Keith and Moos, Rudolf. Can Encouraging Substance Abuse Patients to Participate in Self-Help Groups Reduce Demand for Health Care? A Quasi-Experiemental Study. Alcoholism: Clinical and Experimental Research 25 (2001): 711-716.
Johnson, Bankole and Ait-Daoud, Nassima. Neuropharmacological Treatments for Alcoholism: Scientific Basis and Clinical Findings Psychopharmacology 149 (2000): 327-344.
Johnson,
et al Attenuation of some Alcohol-Induced Mood Changes and the Desire to
Drink by 5-HT3 Receptor Blockade: A Preliminary Study in Healthy Male Volunteers.
Psychopharmacology 112(1993): 142-144
Litten
RZ, Allen J, and Fertig J. Advances in the Development of Medications for
Alcoholism. Psychopharmacology
139 (1998): 20-33
Monti, Peter et al. Naltrexone and Cue Exposure with Coping and Communication Skills Training for Alcoholics: Treatment Process and 1-Year Outcomes Alcoholism: Clinical and Experiemental Research 25 (2001): 1634-1647.
Myers
RD and Veale, WL Alcohol preference in the rat: Reduction following Depletion
of Brain Serotnoin. Science 160 (1968): 1469-1471
Nielsen,
Bent, Neilse, Anette, and Wraae, Olaf. Patient-Treatment Matching Improves
Complaince of Alcoholics in Outpatient Treatment The Journal of Nervous
and Mental Disease 186 (1998): 752-760.
O’Malley
SS, et al Naltrexone and coping skills therapy for Alcohol Dependence: A
Controlled Study Archives of General Psychiatry 49 (1992): 881-887
Poldrugo
F Acamprosate Treatment in a Long-Term Community-based Alcohol Rehabilitation
Program. Addiction 92 (1997): 1537-1546
Sellers,
et al Clinical Efficacay of the 5-HT3 Antagonist
Ondansetron in Alcohol Abuse and Dependence
Alcohol: Clinical and Experimental Research 18(1994):879-885.
Swift,
et al Oncansetron alters Human Alcohol Inotoxication Biological
Psychiatry 40(1996): 514-521
Volpicelli
JR et al Nalterxone in the treatment of Alcohol Dependence Archives of
General Psychiatry 49 (1992): 876-880
Volpicelli
JR et al. Nalterxone and Alcohol Dependence.
Role of Subject Compliance Archives of General Psychiatry 54
(1997): 737-74
Bisaga,
A., Gianelli, P., Popik, P. Opiate Withdrawal with Dextromethorphan American
Journal of Psychiatry. 154
(1997):584
Bisaga,
Adam and Popik, Piotr. In search
of a New Pharmacological Treatment for Drug and Alcohol Addiction: N-methyl-D-aspartate
(NMDA) antagonists Drug and Alcohol Dependence 59 (2000): 1-15
Carroll,
Kathleen Relapse Prevention as a Psychosocial Treatment: A Review of
Controlled Clinical Trials Environmental and Clinical Psychopharmacology
4 (1996): 46-54.
Humphreys,
Keith et al Do Enhanced Friendship Networks and Active Coping Mediate the
Effect of Self-Help Groups on Substance Abuse The Society of Behavioral
Medicine 21 (1999): 54-60.
Killen,
JD, Maccoby N, and Taylor, CB Nicotine Gum and Self-Regulation Training in
Smoking Relapse Prevention Behavior Therapy 15 (1984): 234-248.
Rosen, et al. A Pilot Study of Dextromethorphan in Nalonxone-Precipitated Opiate Withdrawal. European Journal of Pharmacology 307 (1996): 251-257
Turner, Samuel. Comments on Expressed Emotion and the Development of New Treatments for Substance Abuse Behavior Therapy 29 (1998):647-654
May,
Philip, Tuma, Hussain, and Dixon, Wilfrid. For Better or For Worse? The
Journal of Nervous and Mental Disease 165 (1977): 231-239.
Staddon, Susan, et al. Clinical Applications of Pharmacogenetics in Psychiatry. Psychopharmacology 162 (2002): 18-23
Return to the Schizophrenia, Alcoholism, Other Substances, or Improved Technology Section
Return to Megan's Behavioral Genomics Homepage
Return to Megan's Genomics Homepage
Davidson College Psychology Department
© Copyright 2002 Department of Psychology,
Davidson College, Davidson, NC 28036
Send comments, questions, and suggestions to: meshafer@davidson.edu